Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-21

Clinical Trial Update: Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the metformin/glimepiride combination against metformin alone and glimepiride alone in newly diagnosed type 2 diabetes has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)
  • metformin (metformin)
  • metformin/glimepiride (metformin/glimepiride)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED